NYSE:PMC Pharmerica (PMC) Stock Price, News & Analysis → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free PMC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume283,015 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pharmerica alerts: Email Address Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> About Pharmerica Stock (NYSE:PMC)PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.Read More Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> PMC Stock News HeadlinesMarch 30, 2024 | msn.comMedicine shortage hits TB elimination programme in PuneNovember 22, 2023 | msn.comFrom next month, PMC hospitals, maternity homes to get generic medicine storesOctober 6, 2023 | bizjournals.comDavenport Extreme Pools & Spas owner and spouse charged with fraud, theftMay 25, 2023 | thestreet.comPharmerica Stock Falls On Unusually High Volume (PMC)April 20, 2023 | health.usnews.comActivities of Daily Living for SeniorsFebruary 24, 2023 | forbes.comGolden LivingJanuary 17, 2023 | marketwatch.comGas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028November 10, 2022 | marketwatch.comGas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028July 15, 2022 | msn.com9 Medford Residents To Participate In 2022 Pan-Mass ChallengeJanuary 21, 2022 | thestreet.comCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7BDecember 8, 2021 | msn.comView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslySee More Headlines Receive PMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmerica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2017Today6/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Distributors Current SymbolNYSE:PMC CUSIP71714F10 CIK1388195 Webwww.pharmerica.com Phone+1-502-6277000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesGeoffrey G. Meyers (Age 72)Independent Chairman of the Board Gregory S. Weishar (Age 62)Chief Executive Officer, Director Suresh Vishnubhatla (Age 48)Executive Vice President - Long-term Care Operations Berard E. Tomassetti (Age 61)Senior Vice President, Chief Accounting Officer Thomas A. Caneris (Age 54)Senior Vice President, General Counsel, Secretary Robert A. McKay (Age 55)Senior Vice President - Purchasing and Trade Relations Frank E. Collins Esq. (Age 63)Independent Director W. Robert Robert Dahl Jr. (Age 60)Independent Director Marjorie W. Dorr (Age 55)Independent Director Patrick G. LePore (Age 62)Independent Director More ExecutivesKey CompetitorsMcKessonNYSE:MCKCencoraNYSE:CORCardinal HealthNYSE:CAHHenry ScheinNASDAQ:HSICPatterson CompaniesNASDAQ:PDCOView All Competitors PMC Stock Analysis - Frequently Asked Questions How were Pharmerica's earnings last quarter? Pharmerica Co. (NYSE:PMC) announced its quarterly earnings results on Thursday, November, 9th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.49 by $0.03. The firm had revenue of $595.10 million for the quarter, compared to the consensus estimate of $596.80 million. What other stocks do shareholders of Pharmerica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmerica investors own include Capitol Federal Financial (CFFN), Depomed (DEPO), Inovio Pharmaceuticals (INO), Bioblast Pharma (ORPN), Tesla (TSLA), Caterpillar (CAT), Gilead Sciences (GILD) and Horizon Therapeutics Public (HZNP). This page (NYSE:PMC) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredonly trade options on these 5-7 stocksI'm going to reveal the only 5-7 stocks you should be trading. But here's the secret - there's nothing spec...Prosper Trading Academy | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmerica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharmerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.